Cerus (CERS) Cash from Investing Activities (2010 - 2026)
Cerus' (CERS) quarterly Cash from Investing Activities came in at $9.9 million in Q1 2026, up 929.27% year-on-year from $957962.1 in Q1 2025, and up 815.53% quarter-over-quarter from -$1.4 million in Q4 2025.
Cerus (CERS) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Cerus has disclosed Cash from Investing Activities across 17 years of filings, most recently posting $9.9 million for Q1 2026.
- Cash from Investing Activities for Q1 2026 came in at $9.9 million, up 929.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.9 million (up 145.37% YoY), and the FY2025 annual result was -$6.2 million, up 24.17% from the prior year.
- Cash from Investing Activities came in at $9.9 million for Q1 2026 at Cerus, up from -$1.4 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $9.9 million in Q1 2026 to a low of -$7.3 million in Q4 2024.
- The 5-year median for Cash from Investing Activities is -$1.1 million (2025), against an average of $744294.1.
- Peak annual rise in Cash from Investing Activities reached 1851.64% in 2024, while the deepest fall reached 405.15% in 2024.
- Cerus' Cash from Investing Activities stood at $7.4 million in 2022, then climbed by 11.28% to $8.2 million in 2023, then sank by 188.68% to -$7.3 million in 2024, then soared by 81.09% to -$1.4 million in 2025, then jumped by 815.53% to $9.9 million in 2026.
- The last three Cash from Investing Activities figures came in at $9.9 million (Q1 2026), -$1.4 million (Q4 2025), and -$2.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -92.80 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -2.50 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | -298.50 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Cerus | 496.03 Mn | 416.34 Mn | 27.89 Mn | 9.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.86 Mn |
| Mar 31, 2026 | 9.86 Mn |
| Dec 31, 2025 | -1.38 Mn |
| Dec 31, 2025 | -1.38 Mn |
| Sep 30, 2025 | -2.51 Mn |
| Sep 30, 2025 | -2.51 Mn |
| Jun 30, 2025 | -1.09 Mn |
| Jun 30, 2025 | -1.09 Mn |
| Mar 31, 2025 | -1.19 Mn |
| Mar 31, 2025 | -1.19 Mn |
| Dec 31, 2024 | -7.29 Mn |
| Dec 31, 2024 | -7.29 Mn |
| Sep 30, 2024 | 4.82 Mn |
| Sep 30, 2024 | 4.82 Mn |
| Jun 30, 2024 | -7.11 Mn |
| Jun 30, 2024 | -7.11 Mn |
| Mar 31, 2024 | 1.45 Mn |
| Mar 31, 2024 | 1.45 Mn |
| Dec 31, 2023 | 8.22 Mn |
| Dec 31, 2023 | 8.22 Mn |